DIAGNOSTIC REPORT
PATIENT NAME : FOUSEENA REF. DOCTOR : SELF
ACCESSION NO : 4124WH001341 AGE/SEX : 21 Years Female
FOUSEENA PATIENT ID : FOUSF2508024124 DRAWN : 25/08/2023 09:11:04
CLIENT PATIENT ID: RECEIVED : 25/08/2023 09:12:43
ABHA NO : REPORTED : 25/08/2023 12:34:05
Test Report Status Final Results Biological Reference Interval Units
BIOCHEMISTRY
GLUCOSE FASTING,FLUORIDE PLASMA
FBS (FASTING BLOOD SUGAR) 92 Diabetes Mellitus : > or = 126. mg/dL
Impaired fasting Glucose/
Prediabetes : 101 - 125.
Hypoglycemia : < 55.
GLUCOSE, POST-PRANDIAL, PLASMA
GLUCOSE, POST-PRANDIAL, PLASMA 117 Diabetes Mellitus : > or = 200. mg/dL
Impaired Glucose tolerance/
Prediabetes : 140 - 199.
Hypoglycemia : < 55.
Interpretation(s)
GLUCOSE FASTING,FLUORIDE PLASMA-TEST DESCRIPTION
Normally, the glucose concentration in extracellular fluid is closely regulated so that a source of energy is readily available to tissues and sothat no glucose is excreted in the
urine.
Increased in:Diabetes mellitus, Cushing’ s syndrome (10 – 15%), chronic pancreatitis (30%). Drugs:corticosteroids,phenytoin, estrogen, thiazides.
Decreased in :Pancreatic islet cell disease with increased insulin,insulinoma,adrenocortical insufficiency,hypopituitarism,diffuse liver disease,
malignancy(adrenocortical,stomach,fibrosarcoma),infant of a diabetic mother,enzyme deficiency diseases(e.g.galactosemia),Drugs-insulin,ethanol,propranolol
sulfonylureas,tolbutamide,and other oral hypoglycemic agents.
NOTE: While random serum glucose levels correlate with home glucose monitoring results (weekly mean capillary glucose values),there is wide fluctuation within
individuals.Thus, glycosylated hemoglobin(HbA1c) levels are favored to monitor glycemic control.
High fasting glucose level in comparison to post prandial glucose level may be seen due to effect of Oral Hypoglycaemics & Insulin treatment,Renal Glyosuria,Glycaemic
index & response to food consumed,Alimentary Hypoglycemia,Increased insulin response & sensitivity etc.
GLUCOSE, POST-PRANDIAL, PLASMA-High fasting glucose level in comparison to post prandial glucose level may be seen due to effect of Oral Hypoglycaemics & Insulin
treatment, Renal Glyosuria, Glycaemic index & response to food consumed, Alimentary Hypoglycemia, Increased insulin response & sensitivity etc.Additional test HbA1c
**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession
Page 1 Of 1
DR.HARI SHANKAR, MBBS MD
(Reg No - TCMC:62092)
HEAD - Biochemistry &
Immunology
View Details View Report
PERFORMED AT :
DDRC AGILUS PATHLABS LIMITED
Building No. 23/2171 – A1, Ground Floor, Near Triveni Super Market, Marunnukada Junction,Palluruthy, Ernakulam – 682006.
Ernakulam Patient Ref. No. 666000005721978
KERALA, INDIA
Tel : 93334 93334
Email : customercare.ddrc@agilus.in
DIAGNOSTIC REPORT
MC-5897
PATIENT NAME : FOUSEENA REF. DOCTOR : SELF
ACCESSION NO : 4124WH001341 AGE/SEX : 21 Years Female
FOUSEENA PATIENT ID : FOUSF2508024124 DRAWN : 25/08/2023 09:11:04
CLIENT PATIENT ID: RECEIVED : 25/08/2023 09:12:43
ABHA NO : REPORTED :25/08/2023 13:45:04
Test Report Status Final Results Biological Reference Interval Units
SPECIALISED CHEMISTRY - HORMONE
TSH
TSH 1.15 Non-Pregnant : 0.4-4.2 µIU/mL
Pregnant Trimester-wise :
1st : 0.1 - 2.5
2nd : 0.2 - 3
3rd : 0.3 - 3
METHOD : ELECTROCHEMILUMINESCENCE
Interpretation(s)
TSH-Below mentioned are the guidelines for Pregnancy related reference ranges for TSH.
---------------------------------------------------------------------------------------------------------
Levels in TSH
Pregnancy (µIU/mL)
First Trimester 0.1 - 2.5
.
2nd Trimester 0.2 – 3.0
.
3rd Trimester 0.3 – 3.0
-------------------------------------------------------------------------------------------------------
NOTE: TSH concentrations in apparently normal euthyroid subjects are known to be highly skewed, with a strong tailed distribution towards higher TSH values. This is well
documented in the pediatric population including the infant age group.
**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession
Page 1 Of 1
DR.HARI SHANKAR, MBBS MD DR.SMITHA PAULSON,MD
(Reg No - TCMC:62092) (PATH),DPB
HEAD - Biochemistry & (Reg No - TCMC:35960)
Immunology LAB DIRECTOR & CONSULTANT
PATHOLOGIST View Details View Report
PERFORMED AT :
DDRC AGILUS PATHLABS LIMITED
DDRC agilus TOWER, G-131,PANAMPILLY NAGAR,
ERNAKULAM, 682036 Patient Ref. No. 666000005721978
KERALA, INDIA
Tel : 93334 93334
Email : customercare.ddrc@agilus.in
